About C5a anaphylatoxin chemotactic receptor 2
C5a anaphylatoxin chemotactic receptor 2 (C5AR2) is a protein
from Homo sapiens identified by UniProt accession
Q9P296, 337 residues long.
MolForge cross-references it against 0 known binders and
142 disease associations.
Target properties
| Protein name | C5a anaphylatoxin chemotactic receptor 2 |
| UniProt accession | Q9P296 |
| Gene | C5AR2 |
| Organism | Homo sapiens |
| Length | 337 residues |
| Molecular weight | — |
| EC numbers | — |
| Target class | UNCLASSIFIED |
| Subcellular location | — |
| Keywords | — |
Druggability
Target tractability assessment (Open Targets + pocket analysis). No approved drug
| Druggability tier | MEDIUM |
| Druggability score | — |
| Pocket score | — |
| Max clinical phase | — |
Disease associations (142)
Diseases linked to this target (Open Targets).
- neurodegenerative disease · score 0.35
- ovarian cancer · score 0.25
- glioblastoma multiforme · score 0.25
- breast adenocarcinoma · score 0.17
- head and neck squamous cell carcinoma · score 0.16
- Blackfan-Diamond anemia · score 0.06
- neoplasm · score 0.06
- X-linked severe congenital neutropenia · score 0.05
- myeloperoxidase deficiency · score 0.05
- nonimmune chronic idiopathic neutropenia of adults · score 0.05
3D Structure (1)
Experimental (PDB) and predicted (AlphaFold) structures for this protein.
| Structure | Source | Method | Mean pLDDT | Resolution (Å) |
| AF-Q9P296-F1 | alphafold | PREDICTED | 86.48 | — |
Amino-acid sequence (337 residues)
MGNDSVSYEY GDYSDLSDRP VDCLDGACLA IDPLRVAPLP LYAAIFLVGV PGNAMVAWVA GKVARRRVGA TWLLHLAVAD LLCCLSLPIL AVPIARGGHW PYGAVGCRAL PSIILLTMYA SVLLLAALSA DLCFLALGPA WWSTVQRACG VQVACGAAWT LALLLTVPSA IYRRLHQEHF PARLQCVVDY GGSSSTENAV TAIRFLFGFL GPLVAVASCH SALLCWAARR CRPLGTAIVV GFFVCWAPYH LLGLVLTVAA PNSALLARAL RAEPLIVGLA LAHSCLNPML FLYFGRAQLR RSLPAACHWA LRESQGQDES VDSKKSTSHD LVSEMEV
Explore C5a anaphylatoxin chemotactic receptor 2 with MolForge
Find binders, run structure-based screening, and map this target across
diseases and approved drugs with our AI-powered platform.
Browse all targets